Business Description
Pharnext SA
ISIN : FR001400N1P4
Compare
Compare
Traded in other countries / regions
ALPHA.FranceP0X.GermanyPNEXF.USA IPO Date
2019-04-09Description
Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -8.14 | |||||
Debt-to-Equity | -0.77 | |||||
Debt-to-EBITDA | -1.03 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -35.38 | |||||
Beneish M-Score | -33.48 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -82.5 | |||||
3-Year EBITDA Growth Rate | 68.7 | |||||
3-Year Book Growth Rate | 64.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.41 | |||||
Quick Ratio | 0.41 | |||||
Days Sales Outstanding | 1551.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -290.7 | |||||
Shareholder Yield % | -71166.67 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -238870 | |||||
Net Margin % | -275180 | |||||
FCF Margin % | -255630 | |||||
ROA % | -522.79 | |||||
ROIC % | -1677.66 | |||||
ROC (Joel Greenblatt) % | -9461.6 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -1.02 | |||||
EV-to-EBITDA | -1.03 | |||||
EV-to-Forward-EBITDA | -0.7 | |||||
EV-to-Revenue | 2615.8 | |||||
EV-to-Forward-Revenue | 8.07 | |||||
EV-to-FCF | -1.09 | |||||
Earnings Yield (Greenblatt) % | -98.04 | |||||
FCF Yield % | -797100 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PNEXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharnext SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.01 | ||
EPS (TTM) ($) | -5417211.326 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 250000000000 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 250000000000 - 250000000000 | ||
Shares Outstanding (Mil) | 13.21 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharnext SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharnext SA Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Pharnext SA Frequently Asked Questions
What is Pharnext SA(PNEXF)'s stock price today?
The current price of PNEXF is $250000000000.00. The 52 week high of PNEXF is $250000000000.00 and 52 week low is $250000000000.00.
When is next earnings date of Pharnext SA(PNEXF)?
The next earnings date of Pharnext SA(PNEXF) is .
Does Pharnext SA(PNEXF) pay dividends? If so, how much?
Pharnext SA(PNEXF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |